The Evolving Role of Mohs Surgeons in Advancing Management of laBCC
Advertisement
Advertisement
Trending on Dermatology Times
1
Christopher Bunick, MD, PhD, on Expanding Targets in Inflammatory Skin Disease
2
Mona Shahriari, MD, FAAD, on OX40-Targeted Therapy in AD
3
When Innovation Meets Insurance Barriers With Lisa Swanson, MD
4
GLP-1s and Skin Health: Clinical Pearls From Gold and Lal
5